rs55708915

Variant summary

Our verdict is Benign. The variant received -9 ACMG points: 0P and 9B. BP4_StrongBP6BS2

The NM_022089.4(ATP13A2):​c.2836A>T​(p.Ile946Phe) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00151 in 1,614,064 control chromosomes in the GnomAD database, including 7 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: 𝑓 0.00093 ( 0 hom., cov: 33)
Exomes 𝑓: 0.0016 ( 7 hom. )

Consequence

ATP13A2
NM_022089.4 missense

Scores

7
11

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:5B:5O:1

Conservation

PhyloP100: 1.03

Publications

12 publications found
Variant links:
Genes affected
ATP13A2 (HGNC:30213): (ATPase cation transporting 13A2) This gene encodes a member of the P5 subfamily of ATPases which transports inorganic cations as well as other substrates. Mutations in this gene are associated with Kufor-Rakeb syndrome (KRS), also referred to as Parkinson disease 9. Multiple transcript variants encoding different isoforms have been found for this gene.[provided by RefSeq, Nov 2008]
ATP13A2 Gene-Disease associations (from GenCC):
  • Kufor-Rakeb syndrome
    Inheritance: AR Classification: DEFINITIVE, STRONG, MODERATE Submitted by: Genomics England PanelApp, G2P, ClinGen, Labcorp Genetics (formerly Invitae), Illumina
  • autosomal recessive spastic paraplegia type 78
    Inheritance: AR Classification: STRONG, MODERATE, SUPPORTIVE Submitted by: Genomics England PanelApp, Orphanet, Labcorp Genetics (formerly Invitae)
  • parkinsonism due to ATP13A2 deficiency
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -9 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.03157115).
BP6
Variant 1-16988161-T-A is Benign according to our data. Variant chr1-16988161-T-A is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 128469.
BS2
High Homozygotes in GnomAdExome4 at 7 AR gene

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_022089.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
ATP13A2
NM_022089.4
MANE Select
c.2836A>Tp.Ile946Phe
missense
Exon 25 of 29NP_071372.1Q9NQ11-1
ATP13A2
NM_001141973.3
c.2821A>Tp.Ile941Phe
missense
Exon 25 of 29NP_001135445.1Q9NQ11-3
ATP13A2
NM_001141974.3
c.2704A>Tp.Ile902Phe
missense
Exon 24 of 27NP_001135446.1Q9NQ11-2

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
ATP13A2
ENST00000326735.13
TSL:1 MANE Select
c.2836A>Tp.Ile946Phe
missense
Exon 25 of 29ENSP00000327214.8Q9NQ11-1
ATP13A2
ENST00000452699.5
TSL:1
c.2821A>Tp.Ile941Phe
missense
Exon 25 of 29ENSP00000413307.1Q9NQ11-3
ATP13A2
ENST00000341676.9
TSL:1
c.2704A>Tp.Ile902Phe
missense
Exon 24 of 27ENSP00000341115.5Q9NQ11-2

Frequencies

GnomAD3 genomes
AF:
0.000927
AC:
141
AN:
152128
Hom.:
0
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.000362
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000589
Gnomad ASJ
AF:
0.000576
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000414
Gnomad FIN
AF:
0.000283
Gnomad MID
AF:
0.0127
Gnomad NFE
AF:
0.00154
Gnomad OTH
AF:
0.000479
GnomAD2 exomes
AF:
0.000990
AC:
249
AN:
251422
AF XY:
0.00111
show subpopulations
Gnomad AFR exome
AF:
0.000185
Gnomad AMR exome
AF:
0.000781
Gnomad ASJ exome
AF:
0.000397
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.000139
Gnomad NFE exome
AF:
0.00164
Gnomad OTH exome
AF:
0.000978
GnomAD4 exome
AF:
0.00157
AC:
2302
AN:
1461820
Hom.:
7
Cov.:
31
AF XY:
0.00156
AC XY:
1136
AN XY:
727208
show subpopulations
African (AFR)
AF:
0.000209
AC:
7
AN:
33478
American (AMR)
AF:
0.000783
AC:
35
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.000344
AC:
9
AN:
26136
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39698
South Asian (SAS)
AF:
0.000580
AC:
50
AN:
86248
European-Finnish (FIN)
AF:
0.000150
AC:
8
AN:
53410
Middle Eastern (MID)
AF:
0.00347
AC:
20
AN:
5768
European-Non Finnish (NFE)
AF:
0.00187
AC:
2075
AN:
1111962
Other (OTH)
AF:
0.00162
AC:
98
AN:
60396
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.484
Heterozygous variant carriers
0
127
254
382
509
636
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
80
160
240
320
400
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000926
AC:
141
AN:
152244
Hom.:
0
Cov.:
33
AF XY:
0.000739
AC XY:
55
AN XY:
74430
show subpopulations
African (AFR)
AF:
0.000361
AC:
15
AN:
41552
American (AMR)
AF:
0.000589
AC:
9
AN:
15288
Ashkenazi Jewish (ASJ)
AF:
0.000576
AC:
2
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5178
South Asian (SAS)
AF:
0.000415
AC:
2
AN:
4822
European-Finnish (FIN)
AF:
0.000283
AC:
3
AN:
10610
Middle Eastern (MID)
AF:
0.0136
AC:
4
AN:
294
European-Non Finnish (NFE)
AF:
0.00154
AC:
105
AN:
68008
Other (OTH)
AF:
0.000474
AC:
1
AN:
2108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.511
Heterozygous variant carriers
0
8
16
23
31
39
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00130
Hom.:
1
Bravo
AF:
0.000926
TwinsUK
AF:
0.00189
AC:
7
ALSPAC
AF:
0.00104
AC:
4
ESP6500AA
AF:
0.00
AC:
0
ESP6500EA
AF:
0.00198
AC:
17
ExAC
AF:
0.00102
AC:
124
Asia WGS
AF:
0.000289
AC:
1
AN:
3478
EpiCase
AF:
0.00213
EpiControl
AF:
0.00142

ClinVar

ClinVar submissions
Significance:Conflicting classifications of pathogenicity
Revision:criteria provided, conflicting classifications
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
2
2
not provided (4)
-
2
-
Kufor-Rakeb syndrome (2)
-
-
1
ATP13A2-related disorder (1)
-
1
-
Autosomal recessive spastic paraplegia type 78 (1)
-
-
1
Inborn genetic diseases (1)
-
-
1
Kufor-Rakeb syndrome;C5567893:Autosomal recessive spastic paraplegia type 78 (1)
-
-
-
Kufor-Rakeb syndrome;C5230619:ATPase cation transporting 13A2 related juvenile neuronal ceroid lipofuscinosis;C5567893:Autosomal recessive spastic paraplegia type 78 (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.14
BayesDel_addAF
Benign
-0.18
T
BayesDel_noAF
Uncertain
-0.040
CADD
Benign
21
DANN
Benign
0.97
DEOGEN2
Benign
0.23
T
Eigen
Benign
-0.24
Eigen_PC
Benign
-0.047
FATHMM_MKL
Benign
0.71
D
LIST_S2
Uncertain
0.95
D
M_CAP
Uncertain
0.22
D
MetaRNN
Benign
0.032
T
MetaSVM
Uncertain
0.43
D
MutationAssessor
Benign
1.1
L
PhyloP100
1.0
PrimateAI
Uncertain
0.54
T
PROVEAN
Uncertain
-2.5
N
REVEL
Uncertain
0.29
Sift
Benign
0.40
T
Sift4G
Benign
0.20
T
Polyphen
0.012
B
Vest4
0.55
MVP
0.98
MPC
0.85
ClinPred
0.024
T
GERP RS
5.5
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
Varity_R
0.12
gMVP
0.29
Mutation Taster
=74/26
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs55708915; hg19: chr1-17314656; COSMIC: COSV100454519; COSMIC: COSV100454519; API
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.